Cramer's Top Stock Picks: IP SNY LSI BAC
Sanofi (SNY - Get Report): Cramer spoke with CEO Chris Viehbacher about this drug maker's remarkable transition from patented drugs and into more stable endeavors such as animal health, vaccines and orphan drugs to treat rare diseases.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts